menu

CME: Clinical & Treatment Challenges of Serborrheic Keratosis: Still Stuck on the Surface of Care

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Clinical & Treatment Challenges of Seborrheic Keratosis: Still Stuck on the Surface of Care

Program Information
Recommended
Clinical & Treatment Challenges of Seborrheic Keratosis: Still Stuck on the Surface of Care
RestartResume
This activity addresses clinical practice gaps relating to the diagnostic and treatment challenges clinicians face in seborrheic keratosis.

Available credits: 1.00

Time to complete: 1 hour

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This CME-certified activity is designed to address clinical practice gaps as identified by our expert faculty relating to the diagnostic and treatment challenges clinicians face in seborrheic keratosis (SK). This program focuses on increasing the abilities of dermatologists and other clinicians to make informed, evidence-based diagnostic and treatment decisions in order to improve clinical outcomes in patients with SK.

  • Target Audience

    This activity has been designed to meet the educational needs of healthcare providers who care for patients with seborrheic keratosis.

    Media: Internet

  • Learning Objectives

    At the conclusion of this educational initiative, participants will be better able to:

    • Explain the importance of the differentiation of various skin lesions with similar clinical features such as SK compared to the appearance of melanoma
    • Distinguish between the clinical presentation of benign vs. inflamed SK lesions and apply evidence-based treatment using recently approved therapies vs. cryotherapy or other procedures
    • Describe the financial challenges associated with SK treatment including reimbursement policies vs. self-pay procedures
    • Counsel patients on the different treatment options with variable costs for SK
  • Accreditation and Credit Designation Statements

    In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and HealthmattersCME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physician Continuing Medical Education

    The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Disclosure of Conflicts of Interest

    Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

    Name of Faculty or Presenter

    Reported Financial Relationship

    Glynis Ablon, MD, FAAD
    Associate Clinical Professor U.C.L.A. Ablon Skin Institute and Research Center
    Los Angeles, CA

     

    Nothing to disclose

     

    Brian Berman, MD, PhD
    Professor Emeritus of Dermatology and Cutaneous SurgeryUniversity of Miami Miller School, Miami,FL
    Co-Director Center for Clinical and Cosmetic Research Skin and Cancer Associates, Aventura, FL

    Advisory Board: Aclaris

    Contracted Research: Aclaris

    Stock Options – Less than 5%: Aclaris

     

    Mark S. Nestor, MD, PhD
    Director, Center for Clinical and Cosmetic Research™ and the Center for Cosmetic Enhancement®, Aventura, Florida
    Voluntary Professor, Department of Dermatology and Cutaneous Surgery and the Department of Surgery, Division of Plastic Surgery University of Miami, Miller School of Medicine

    Advisory Board: Aclaris; Aerolase; Almirall; Bioderma; Biofrontera; BirchBioMed; Castle BioSciences; Essence Novel; Ferndale Laboratories; Galderma; IntraDerm; Isdin; Johnson & Johnson; LEO Pharma; Sensus Healthcare; Sinclair Pharma; Stratapharma; Thermi

    Consultant: Afecta; Almirall; CROMA Pharma GmbH; Ferndale Laboratories; Johnson & Johnson; Rohrer Aesthetics; Sensus Healthcare; Sinclair Pharma; Thermi

    Investigator: Aclaris; Actavis; Aerolase; Afecta; Allergan; Biofrontera; BirchBioMed; Brickell; Biotech; Celgene Corp; CROMA Pharma GmbH; Demira; Encore Dermatology, Inc; Evolus, Inc.; Exeltis USA Dermatology, LLC; Ferndale Laboratories; Gage Development, Co.; Galderma; IFC, S.A.; ncyte Corp.; IntraDerm; Johnson & Johnson; LEO Pharm; MC2 Therapeutics; Menlo Therapeutics; miRagen Therapeutics, Inc.; Pulse Biosciences; SASIF; Sinclair Pharma; Sirnaomics; Therapeutics, Inc.; Vanda Pharmaceuticals

    Speaker: Aerolase; IFC, S.A.; IntraDerm; Rohrer Aesthetics; SASIF; Sensus Healthcare; Thermi

    Planners and Managers
    The PIM planners and managers have nothing to disclose. The HealthmattersCME planners and managers have nothing to disclose.

  • Disclosure of Unlabeled Use

    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

  • Request for Credit

    1. Review the activity objectives and CME/CE information.
    2. Complete the CME/CE activity.
    3. Complete the online posttest. The participant may take the test until successfully passed.
    4. Complete the CME/CE evaluation form, which provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
    5. After completing the CME/CE evaluation, participant can claim credit and receive certificate via participant's ReachMD account history to download the certificate. Participants will also be notified via email with a direct link to the certificate to download/print.
  • Provider(s)/Educational Partner(s)

    This activity is jointly provided by Postgraduate Institute for Medicine and HealthmattersCME.

    This activity is supported by an independent educational grant from Aclaris Therapeutics.

     

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 9/21/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.